Physician profile
Daniel M Buerkel
NPI 1417075987
$4,760.39
in general payments reported to CMS, 2019-2025
13 companies · $1,160 in 2025
The $1,160 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $618 · 2020: $285 · 2021: $159 · 2022: $506 · 2023: $146 · 2024: $1,885 · 2025: $1,160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,438 · Food and Beverage: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,438.17 |
| Food and Beverage | $753.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,172.11 | 2021-2025 | Azure Xt Dr Mri Surescan, Affera Mapping System, Linq II |
| Biotronik INC. | $953.41 | 2019-2025 | |
| Abbott Laboratories | $725.19 | 2019-2022 | |
| Biosense Webster, INC. | $300.16 | 2019-2023 | Carto 3 |
| Boston Scientific Corporation | $262.60 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Ingevity Mri |
| Medtronic Vascular, INC. | $144.02 | 2020 | |
| Janssen Pharmaceuticals, INC | $91.81 | 2021-2022 | |
| Pfizer INC. | $30.55 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $18.71 | 2022 | |
| Scpharmaceuticals INC. | $16.76 | 2024 | |
| Philips North America LLC | $16.64 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.02 | 2024 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Buerkel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.